Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Indaptus Therapeutics, Inc. (INDP) had Free Cash Flow of $-8.94M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.79M |
|
-- |
|
-- |
|
$1.81M |
|
$-1.81M |
|
$0.01M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.81M |
|
$-1.81M |
|
116.13M |
|
116.13M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$11.99M |
|
-- |
|
-- |
|
$11.99M |
|
$0.62M |
|
-- |
|
-- |
|
$0.62M |
|
$11.37M |
|
$11.37M |
|
$11.37M |
|
133.24M |
|
| Cash Flow Statement Financials | |
$-8.94M |
|
$-4.00M |
|
$11.98M |
|
$8.51M |
|
$7.55M |
|
$-0.95M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-8.94M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.78% |
|
-15.78% |
|
-14.97% |
|
-15.78% |
|
$0.09 |
|
$-0.08 |
|
$-0.08 |
|